JMP Securities Reiterates Market Outperform on Enanta Pharma, Maintains $22 Price Target

Benzinga · 09/27 14:51
JMP Securities analyst Roy Buchanan reiterates Enanta Pharma (NASDAQ:ENTA) with a Market Outperform and maintains $22 price target.